Evidence map›Paper›PMID 42675959›Full record

ArticleJournal of veterinary emergency and critical care (San Antonio, Tex. : 2001)

Use of Intralipid Therapy and Therapeutic Plasma Exchange in the Management of Cholecalciferol Rodenticide Exposure in a Dog: A Case Report.

Tanvi A Kamat, Kara D Altman, Emma Donnelly, Neus Elias Santo-Domingo

Abstract readCase Reports
In one paragraph

Article in Journal of veterinary emergency and critical care (San Antonio, Tex. : 2001). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tanvi A KamatVetsNow 24/7 Pet Emergency & Specialty Hospital, Glasgow, UK.
Kara D AltmanVetsNow 24/7 Pet Emergency & Specialty Hospital, Glasgow, UK.
Emma DonnellyVetsNow 24/7 Pet Emergency & Specialty Hospital, Glasgow, UK.
Neus Elias Santo-DomingoVetsNow 24/7 Pet Emergency & Specialty Hospital, Glasgow, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the presentation and outcome of a case of suspected cholecalciferol rodenticide intoxication managed with both intralipid emulsion (ILE) and therapeutic plasma exchange (TPE). CASE SUMMARY: A 3-year-old, neutered female, crossbreed dog presented for acute-onset vomiting and lethargy after suspected exposure to cholecalciferol rodenticide. Severe hypercalcemia was observed without other identifiable causes found upon investigation. Standard therapy for hypercalcemia was initiated, but rebound hypercalcemia led to consideration of alternative management options. Although ILE therapy initially showed promise, rebound hypercalcemia persisted. Ultimately, TPE was performed as a novel therapy and successfully reduced serum concentrations of vitamin D metabolites. Normocalcemia was eventually maintained, though the dog developed endocarditis that progressed to congestive heart failure and death. Blood cultures revealed the growth of Serratia marcescens. NEW OR UNIQUE INFORMATION PROVIDED: To the authors' knowledge, this is the first report describing the use of both ILE and TPE in the management of cholecalciferol rodenticide intoxication in a dog. It is also the second reported case of S. marcescens causing endocarditis in a dog.

Indexed as

CholecalciferolDog DiseasesFat Emulsions, IntravenousPhospholipidsPlasma ExchangeRodenticidesSoybean OilAnimalsDogsEmulsionsFemaleCholecalciferolEmulsionsFat Emulsions, IntravenousPhospholipidsRodenticidesSoybean Oilsoybean oil, phospholipid emulsioncanineextracorporeal therapyintoxicationvitamin D

Identifiers

PMID42675959
PMCPMC13676803

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.